Combating Drug Resistant Bacterial Infections
Our novel antibiotic is being developed for treatment of antibiotic resistant pathogens such as MRSA.
Advisors
Our advisors combine real-world expertise with decades of academic research experience. They provide consult in niche scientific challenges encountered during research and development, and offer insights into new projects Sano undertakes.
